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ABSTRACT 
Objective: Antibiotics are frequently prescribed because of clinical suspicion of infection, while the results of the microbiological analysis are still 
awaited. This study was undertaken to assess the impact of microbiological culture results on the antibiotic prescribing pattern.  
Methods: This prospective observational study was conducted on 400 patients of either sex and any age with positive microbiological culture 
results. Empirical antibiotic therapy details were recorded and change in empirical antibiotic therapy after positive culture results was also 
recorded. Assessment of sensitivity resistance pattern of microorganisms was also performed. 
Results: In the study, male: female ratio was 1.01:1. The majority of patients i.e. 94 (24.50%) were in the 46 y to 60 y of age group. Definitive 
antibiotic therapy was initiated in 103 patients (25.75%) out of 400 patients. The highest number of changes in antibiotic therapy was done in 
urinary tract infections (63.95%) and septicemia (32.61%) cases. Klebsiella (34.25%), E. coli (32%) and Staphylococcus aureus (14.75%) were 
commonly isolated microorganisms. Cephalosporins (77.75%) and aminoglycosides (47%) were commonly used in empirical antibiotic therapy, 
while nitrofurantoin (47.57%) and penicillins (22.33%) were commonly used in definitive antibiotic therapy. Definitive antibiotic therapy was 
associated with a reduced duration of hospital stay as compared to empirical antibiotic therapy (p<0.0001). 
Conclusion: Antibiotic prescribing is infrequently influenced by microbiological culture results. Adjustment of the antimicrobial therapy according 
to microbiological culture results can decrease the duration of hospital stay as well as can decrease the spread of antimicrobial resistance. 
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INTRODUCTION 
The appropriate use of antibiotics is an important aspect of the 
treatment of infections. Antibiotics are frequently prescribed 
because of clinical suspicion of infection while the results of the 
microbiological analysis are still awaited [1].  
Early clinical recognition of infection, rapid laboratory detection of 
the causative organisms and prompt initiation of appropriate 
antimicrobial therapy are all essential aspects of the management of 
severe infections. When the pathogens and their susceptibilities are 
determined, streamlining and adapting antimicrobial regimens are 
important to ensure optimal treatment and to limit the untoward 
consequences of the misuse of antimicrobial agents, particularly the 
selection of resistant microorganisms and excessive cost of 
treatment [2]. 
Several strategies have been suggested to improve antibiotic 
prescribing such as surveillance of antibiotic resistance, monitoring 
and auditing of antibiotics use, the use of consensus guidelines or 
computer decision support and improving multidisciplinary co-
operation [3]. 
Empirical antibiotic therapy may be influenced by microbiological 
culture results either by broadening or narrowing of the spectrum of 
antibiotics or by discontinuation of therapy in case of negative 
cultures. To limit the emergence and spread of resistance, antibiotic 
therapy should be adjusted according to the results of the 
microbiological culture [4].  
The results of microbiological cultures are often ignored because the 
patients are doing well on empirical therapy. Although 
microbiological studies form the basis of effective treatment, 
clinicians and hospital services show varying degrees of interest in 
microbiological analysis to decide the appropriate treatment [5-7].  
Although the appropriateness of antibiotic prescribing has been 
investigated frequently, the impact of microbiological culture results 
on antibiotic prescribing has not been analyzed frequently; 
therefore, this study was designed to analyze how the results of 
microbiological cultures influence antibiotic use in the treatment of 
infection. The assessment of the sensitivity resistance pattern of 
microorganisms was considered a secondary objective of the study. 
MATERIALS AND METHODS 
This study was a prospective observational study which was 
conducted at P. D. U. Government Medical College and Hospital, 
Rajkot, Gujarat, from March-2014 to February-2015 after 
permission of the Institutional Ethics Committee 
[PDUMCR/IEC/9067/2014]. 
A total of 400 patients of either sex and of all age who were admitted 
in the hospital, given empirical antibiotic therapy and tested positive 
on microbiological culture followed by sensitivity testing were 
included in the study. The patients having malaria, tuberculosis and 
human immunodeficiency virus infection were excluded from the 
study because of specific antimicrobial therapy for these diseases. 
Pregnant women, immunocompromised and cancer patients were 
also excluded from the study. 
The patients with positive microbiological culture sensitivity testing 
were enrolled in the study after their informed written consent. Patient 
details like age, sex, diagnosis, type of specimen collected, isolated 
microorganisms and their sensitivity/resistance pattern was recorded 
from the laboratory reports. In these patients, empirical antibiotic 
therapy details like an antimicrobial drug; its dose, route of 
administration, frequency and duration of treatment before culture 
sensitivity testing were noted from their respective case notes and 
treatment charts. Change in empirical therapy after culture sensitivity 
reports were also recorded. Assessment of sensitivity and resistance 
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pattern of isolated microorganisms at the hospital was considered as a 
secondary objective of the study. The recorded data were analyzed by 
Microsoft Office Excel 2013 and using descriptive statistics. 
RESULTS 
In this study, out of 400 patients, 201 (50.75%) were males and 199 
(49.25%) were females with a male: female ratio of 1.01:1. The mean age 
of the patients was 32.61±22.74 y with a range of 1 d to 95 y. The highest 
number of patients i.e. 94 (24.50%) were in the 46 y to 60 y of age group. 
Out of 400 patients, definitive antibiotic therapy was initiated in 103 
(25.75%) patients after culture sensitivity testing. Table 1 shows the 
isolated microorganisms during the study and the number of 
patients receiving definitive antibiotic therapy according to isolated 
microorganisms. 
 
Table 1: Number of patients receiving definitive antibiotic therapy according to isolated microorganisms 
S. No. Isolated microorganism Total No. of patients (N=400) No. patients receiving definitive antibiotic therapy (N=103) 
1 Klebsiella 137 33 
2 E. coli 128 43 
3 Staphylococcus aureus 59 7 
4 Pseudomonas 44 9  
5 Proteus mirabilis 10 3 
6 Acinetobacter 7 3 
7 Providencia rettgeri 4 1 
 
Isolated microorganisms like Providencia Stuartii, Enterobacter, 
Streptococcus and Salmonella Paratyphi-B were less than 2 in 
number and Isolated like Proteus Vulgaris and Morgenella, where no 
change in therapy was done, are not mentioned in the table 1. 
The patients with 45 different conditions were enrolled in the study out 
of which urinary tract infection (UTI) was the most common clinical 
diagnosis. Table 2 shows the number of patients receiving definitive 
antibiotic therapy according to the first 10 most common diagnoses.
 
Table-2: Number of patients receiving definitive antibiotic therapy according to the first 10 most common diagnoses 
S. No. Diagnosis Total No. of patients (N=225) No. patients receiving definitive antibiotic therapy (%) (N=85) 
1 UTI 86 55 (63.95) 
2 Septicemia 46 15 (32.61) 
3 Burns 25 5 (20) 
4 Pemphigus vulgaris 23 3 (13.04) 
5 Pneumonitis 21 3 (14.29) 
6 Diarrhoea 21 0 
7 Cellulitis 16 0 
8 Diabetic foot 15 0 
9 Acute osteomyelitis 15 1 (6.67) 
10 Chronic suppurative otitis media 12 3 (25) 
 
Among 400 patients who received empirical antibiotic therapy, 
cephalosporin [n=311 (77.75%)] was the most commonly 
prescribed group of antimicrobials in which ceftriaxone was the 
most common drug. After cephalosporin, aminoglycosides [n=188 
(47%)] were commonly used in which amikacin was the most 
common drug. Other antimicrobials which were used as an 
empirical antibiotic therapy included: fluoroquinolones [n=118 
(29.5%)], nitroimidazoles [n=106 (26.5%)], penicillins [n=58 
(14.5%)], macrolides [n=8 (2%)], tetracyclines [n=2 (0.5%)] and 
glycopeptides [n=1, (0.25%)]. Out of 400 patients, 291 patients 
received two antimicrobials and 50 patients received three 
antimicrobials as empirical antibiotic therapy. 
Among 103 patients who received definitive antibiotic therapy, 
urinary antiseptic [n=49 (47.57%)] like nitrofurantoin was the most 
commonly used drug followed by penicillin group [n=22 (21.35%)] 
of drug which included piperacillin. Other antimicrobials which 
were used as definitive antibiotic therapy included: 
fluoroquinolones [n=16 (15.53%)], cephalosporins [n=15 
(14.56%)], aminoglycosides [n=13 (12.62%)], glycopeptides [n=3 
(2.91%)], macrolides [n=3 (2.91%)], tetracyclines [n=2 (1.94%) and 
nitroimidazoles [n=1, (0.97%)]. Out of 103 patients who received 
definitive antibiotic therapy, 19 patients received two antimicrobials 
and 1 patient received three antimicrobials. 
Mean duration of stay in empirical and definitive antibiotic therapy 
was 3.90±1.43 d and 2.72±0.56 d, respectively, which showed that 
there was a decreased duration of hospital stay in definitive 
antibiotic therapy as compared to empirical antibiotic therapy 
having p-value<0.0001 by Mann-Whitney test calculated in 
GraphPad Prism software (version 6.07). Table 3 shows the 
difference between the mean duration of stay in empirical and 
definitive antibiotic therapy according to the first 10 most common 
diagnoses.
 
Table 3: Mean duration of stay in empirical and definitive therapy according to the first 10 most common diagnoses 
S. No. Diagnosis Mean duration of stay (days) in empirical 
antibiotic therapy 
Mean duration of stay (days) in definitive antibiotic 
therapy 
1 UTI 3.27 2.94 
2 Septicemia 5.77 2.23 
3 Burns 3.96 2.40 
4 Pemphigus vulgaris 3.61 3 
5 Pneumonitis 3.52 3 
6 Diarrhoea 2.35 0 
7 Cellulitis 4.33 0 
8 Diabetic foot 3.18 0 
9 Acute osteomyelitis 3.76 2 
10 Chronic suppurative 
otitis media 
2.78 1.66 
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During the study, the most commonly isolated microorganisms 
were from Enterobacteriaceae group [n=288 (72%)] followed by 
other gram-negative bacteria [n=51 (12.75%)] and gram-
positive organisms [n=61 (15.25%)]. Table 4 shows the culture 
sensitivity testing results of all isolated microorganisms during 
the study. 
 
Table 4: Culture sensitivity testing results 
S. No. Antimicrobial 
group/Drug 
Enterobacteriaceae Other Gram-negative1 Gram-positive2 3 
No. of different 
agent tested 




No. of different 
agent tested 
Sensitive (%) 
1 Cephalosporins 688 247 (35.90) 62 41 (66.13) 61 44 (72.31) 
2 Penicillins 433 212 (48.96) 50 38 (76) 83 9 (10.84) 
3 Aminoglycoside 297 149 (50.17) 54 26 (48.15) 17 3 (17.65) 
4 Fluoroquinolone 292 168 (57.53) 35 24 (68.57) 36 28 (77.78) 
5 Co-trimoxazole 180 63 (35) 4 1 (25) 32 21 (65.63) 
6 Nitrofurantoin 95 79 (83.16) 4 0 - - 
7 Meropenem 82 81 (98.78) 12 12 (100) - - 
8 Tetracyclines 65 11 (16.92) 1 0 19 15 (78.95) 
9 Aztreonam 48 30 (62.50) 14 11 (78.57) 1 1 (100) 
10 Glycopeptides 9 7 (77.78) 1 0 96 96 (100) 
11 Linezolid 7 2 (28.57) 1 0 59 59 (100) 
12 Macrolides 5 4 (80) 1 0 62 28 (45.16) 
13 Others  76 33 (43.42) 44 44 (100) 99 81 (81.82) 
1=Klebsiella, E. coli, Proteus mirabilis, Proteus vulgaris, Providencia rettgeri, Providencia stuartii, Morgenella and Enterobacter; 2=Pseudomonas and 
Acinetobacter; 3=Staphylococcus aureus and Streptococci 
 
DISCUSSION 
Much concern has been voiced in the last two decades about the 
widespread use of antimicrobial agents, including broad-spectrum 
antibiotics, leading to the emergence of multiple drug-resistant 
microorganisms. 
This study assessed the impact of microbiological culture results on 
antibiotic prescribing pattern. Among positive culture sensitivity 
testing, antibiotic prescribing was influenced only in 25.75% of 
patients which is consistent with the study done by Maraha et al. in 
which it was 32% of all enrolled patients [8]. A similar study was 
performed by Gyssens et al. which showed approximately 50% 
change in empirical antibiotic therapy after culture sensitivity 
testing which is higher than our study [9]. Another study was 
conducted in a British district general hospital where 
microbiological culture sensitivity testing resulted in modification of 
therapy in 67% of the cases [10].  
UTI patients’ isolates showed E. coli and Klebsiella in their cultures 
and were given ceftriaxone and norfloxacin as empirical antibiotic 
therapy but these isolates were resistant to these drugs. This may be 
suggestive of the highest use of drugs like nitrofurantoin and 
levofloxacin in definitive antibiotic therapy as changes in the 
empirical antibiotic therapy in these cases were according to the 
sensitivity pattern of isolated microorganisms. This sensitivity 
pattern was consistent with the study done by Shalini et al. in which 
Klebsiella had 75.86% and 72.41% sensitivity to nitrofurantoin and 
levofloxacin, respectively and E. coli had 93.86% and 75% sensitivity 
to nitrofurantoin and levofloxacin, respectively [11].  
Septicemia cases showed Klebsiella, Pseudomonas and Providencia 
rettgeri in their culture isolates. These patients were given either 
ampicillin and gentamicin or cefotaxime and amikacin as empirical 
antibiotic therapy. As some of these isolates were resistant to 
ampicillin and gentamicin, such patients were given cefotaxime and 
amikacin as definitive antibiotic therapy. Those patients who were 
also resistant to cefotaxime and amikacin; and who showed 
pseudomonas in culture isolates were given piperacillin as definitive 
antibiotic therapy. In our study, piperacillin was 100% sensitive to 
pseudomonas and 98.53% to enterobacteriaceae isolates which is 
suggestive of the use of this drug as definitive antibiotic therapy in 
septicemia cases. 
Staphylococcus aureus was the most commonly isolated gram-
positive microorganism. The highest number of changes in empirical 
antibiotic therapy was done in pemphigus vulgaris cases among 
Staphylococcus aureus isolates and these patients were given 
vancomycin as definitive antibiotic therapy because it was 100% 
sensitive. The study performed by Duran et al. also showed a similar 
sensitivity pattern to Staphylococcus aureus [12].  
Enterobacteriaceae group of microorganisms like Klebsiella, Proteus, 
E. coli and Enterobacter and other gram-negative organisms like 
pseudomonas constitute the highest number of the isolated 
microorganisms in our study and they are the commonest cause of 
hospital-acquired infections. These microorganisms are more 
resistant to the commonly used antimicrobial drugs of empirical 
antibiotic therapy. To prevent the development of such nosocomial 
infection, guidelines provided by the World Health Organization 
(WHO) on prevention of nosocomial infection should be followed 
such as reducing person-to-person transmission and preventing 
transmission from the environment [13].  
As the 3rd
Older drugs like co-trimoxazole showed more sensitivity (65.53%) 
to gram-positive organisms as compared to macrolides (45.16%) 
and penicillins (10.84%). Therefore, these drugs can be used as 
empirical antibiotic therapy in gram-positive infected patients. 
 generation cephalosporins and aminoglycosides are 
commonly used as empirical antibiotic therapy in gram-negative 
microorganism infected cases, these microorganisms show increased 
resistance to these drugs in our hospital which is a growing concern 
for the treatment of such infections. For the prevention of 
development of resistance, antimicrobial stewardship programme 
should be initiated in the hospital along with the formation of 
guidelines for effective use of antimicrobials at the hospital. 
Antimicrobial stewardship programmes have been shown to reduce 
inappropriate antimicrobial use, reductions in antimicrobial resistance 
and improved clinical outcomes for patients [14].  
Antibiotic therapy should be changed according to microbiological 
culture sensitivity testing results as there is a statistically significant 
difference (p<0.0001) in the duration of hospital stay in definitive 
and empirical antibiotic therapy. This practice can reduce the spread 
of antimicrobial resistance as well as can decrease the cost of the 
therapy [15].  
Sensitivity resistance pattern of the microorganism at a local level of 
the hospital can be formed for the rational use of the antibiotics and 
to prevent the development of resistance. The development of 
effective control programs through the adoption of measures that 
restrict the use of specific antimicrobials, the establishment of 
therapeutic guidelines, the constant monitoring of the resistance 
pattern of the common pathogenic organisms in the hospital are 
recommended to improve the usage of antibiotics [16].  
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Infectious disease specialists can play a significant role in the 
management of infections. They can improve the appropriateness of 
the antimicrobial treatment at no extra cost [17]. Study performed 
by Byl et al. emphasizes the importance of close coordination among 
the clinical laboratory, the infectious disease specialists and 
physicians in ensuring optimal care for severely infected patients. 
They also underscore the need to foster the education of physicians 
in the field of antimicrobial therapy for the management of 
infections [18].  
The future of antibiotics and the survival of every human being that 
acquires a bacterial infection will depend on the serious commitment 
of many stakeholders including government authorities, policymakers, 
health-care workers, pharmaceutical companies and consumers. 
Solutions for antimicrobial resistance will not be easy and 
paradoxically increasing the price of antibiotics might restrict their use 
but a delicate balance between overuse and lack of access is to be 
maintained. There is a room for innovative ideas in quality assurance, 
health financing and social marketing [19].  
There is a need to formulate antibiotic policies in every hospital 
because the resistance of pathogenic microorganisms to 
antimicrobial agents is increasing and it is difficult to keep pace with 
the development of resistance. Similar studies should be done on a 
larger scale and at regular intervals which can reflect the change in 
the sensitivity resistance pattern of microorganisms towards the 
antimicrobial agents. There is a need to develop new antimicrobial 
agents which are becoming an “endangered species” owing to loss of 
interest by pharmaceutical companies in developing newer drugs on 
one end and development of resistance on the other end. 
Appropriate and cautious use of antimicrobials has become a 
necessity for us to continue the use of these “wonder drugs”.  
There were certain limitations of this study. The first limitation 
was that culture sensitivity testing for all the antimicrobial drugs 
was not performed throughout the study due to availability of 
culture sensitivity testing kits. The second limitation was that the 
specimens which did not show any culture isolates were not 
included in the study (only 8-10 samples show positive culture 
isolates out of daily average of 40 samples). This was a one-time 
study, continuous review of sensitivity profile of various 
microorganisms should be performed regularly. 
CONCLUSION 
In conclusion, our data show that antibiotic prescribing is 
infrequently influenced by microbiological culture results. However, 
this does not imply that microbiological investigations are not 
essential in the diagnostic process when the infection is suspected. A 
review of the microbiological results of patients receiving antibiotics 
may be an effective approach to integrate microbiological results 
into medical practices and to improve antibiotic prescribing. 
Adjustment of the antimicrobial therapy according to 
microbiological culture results can decrease the duration of hospital 
stay and the spread of antimicrobial resistance. 
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